DENIM Clinical Study
The official title of the DENIM clinical study is: Dendritic Cell-based immunotherapy to treat Malignant Mesothelioma (H2020MM04).
In the DENIM clinical trial, standard chemotherapy is followed by either Best Supportive Care or dendritic cell immunotherapy called MesoPher®. These two treatment options will be compared.
Inclusion for the DENIM study will start in the second half of 2017.
Prof. Joachim Aerts MD PhD, pulmonary oncologist at Erasmus MC is coordinator of the DENIM study.